- Home
- XOMAP vs RIG Comparison
XOMAP vs RIG Comparison
Compare XOMAP & RIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMAP
- RIG
- Stock Information
- Founded
- XOMAP N/A
- RIG 1926
- Country
- XOMAP United States
- RIG Switzerland
- Employees
- XOMAP 13
- RIG N/A
- Industry
- XOMAP Biotechnology: Pharmaceutical Preparations
- RIG Oil & Gas Production
- Sector
- XOMAP Health Care
- RIG Energy
- Exchange
- XOMAP Nasdaq
- RIG Nasdaq
- Market Cap
- XOMAP N/A
- RIG N/A
- IPO Year
- XOMAP N/A
- RIG 1993
- Fundamental
- Price
- XOMAP $26.76
- RIG $3.07
- Analyst Decision
- XOMAP
- RIG Hold
- Analyst Count
- XOMAP 0
- RIG 9
- Target Price
- XOMAP N/A
- RIG $4.25
- AVG Volume (30 Days)
- XOMAP N/A
- RIG 21.0M
- Earning Date
- XOMAP N/A
- RIG 10-29-2025
- Dividend Yield
- XOMAP N/A
- RIG N/A
- EPS Growth
- XOMAP N/A
- RIG N/A
- EPS
- XOMAP N/A
- RIG N/A
- Revenue
- XOMAP N/A
- RIG $3,794,000,000.00
- Revenue This Year
- XOMAP N/A
- RIG $11.52
- Revenue Next Year
- XOMAP N/A
- RIG N/A
- P/E Ratio
- XOMAP N/A
- RIG N/A
- Revenue Growth
- XOMAP N/A
- RIG 23.26
- 52 Week Low
- XOMAP N/A
- RIG $1.97
- 52 Week High
- XOMAP N/A
- RIG $4.76
- Technical
- Relative Strength Index (RSI)
- XOMAP 65.35
- RIG 54.05
- Support Level
- XOMAP $25.85
- RIG $2.93
- Resistance Level
- XOMAP $26.75
- RIG $3.21
- Average True Range (ATR)
- XOMAP 0.21
- RIG 0.13
- MACD
- XOMAP 0.09
- RIG 0.00
- Stochastic Oscillator
- XOMAP 86.89
- RIG 67.78
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.